Paper
31 January 2001 Clinical results of stereotactic intratumoral photodynamic therapy for malignant brain tumors
Sadao Kaneko
Author Affiliations +
Abstract
30 malignant brain tumors of 25 cases, that were seated deeply in the brain or in an eloquent area, were treated with stererotactic intratumoral PDT using HPE and argon-dye laser. 3mg/kg HPE was administered iv 2 days after, a stereotactic apparatus was installed and target points were determined by enhanced CT or MRI. Optical fiber was inserted into predetermined target points of tumor by stereotactic methods, and photo illumination with power output 200 mW was applied for 15 minutes. The photo illumination was repeated several times depending on tumor volume. All tumors clearly showed a reduction in tumor volume 4 weeks after stererotactic PDT. A complete response was obtained in 19 tumors, PR was in 8 tumors, NC was in 3 tumors. In the case of 22.9 ml or lower volume, therapeutic effects were obtained for all of them. The largest tumor which showed complete disappearance on enhanced CT or MRI had a volume of 4.6 ml. This study indicates that it is possible to consider stereotactic intratumoral PDT showing adequate therapeutic effects as an adjuvant therapy for malignant brain tumors.
© (2001) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Sadao Kaneko "Clinical results of stereotactic intratumoral photodynamic therapy for malignant brain tumors", Proc. SPIE 4156, Clinical Lasers and Diagnostics, (31 January 2001); https://doi.org/10.1117/12.413723
Lens.org Logo
CITATIONS
Cited by 1 scholarly publication.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Photodynamic therapy

Brain

Chromium

Computed tomography

Magnetic resonance imaging

Neuroimaging

Back to Top